Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Characteristics of Germinal Peptide Eye Drops in Healthy Volunteers
NCT03967548Phase 1Completed
- Sponsor
- Zhaoke Ophthalmology
- Start
- Apr 2021
- Primary completion
- May 2021
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of germinal peptide in Corneal epithelial defect, sponsored by Zhaoke Ophthalmology. Primary endpoints: Area under curve (0-t) at 12 hours, Area under curve (0-infinity) at 12 hours and 7 more. Started Apr 2021; status: completed.
02
Drugs
germinal peptide
03
Conditions
Corneal epithelial defect
Beyond the preview
Go deeper on NCT03967548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03967548.